Harmony Biosciences Holdings, Inc. (HRMY) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGM. Market cap 2.31B USD. 52-week range 25.52 to 43.49 USD. Trailing P/E 12.8. Data as of 2026-10-09.
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also develops Pitolisant that is in Phase 3 clinical trial for the treatment of Prader-Willi Syndrome (PWS); in Phase 2 clinical ...